home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/e1ab947e-7c05-4dfb-b5fd-488cad789f05_What-Pharma-Should-Do-About-Artificial-IntelligenceAI-.pdf
whitepaper
SHARESHARESHARE
WHAT PHARMA SHOULD DO ABOUT ARTIFICIAL INTELLIGENCE (AI)
AI has the potential to provide huge benefits to the pharmaceutical industry, from improving R&D productivity through to more effective sales representative deployment and better supply chain management. Adoption of AI is lagging other sectors, with initial forays mainly being led by big pharma who have deep pockets and are willing to try new innovations. For many, however, it remains misunderstood, or even feared. Given the transformative potential of AI, companies must understand their benefits and develop strategies that meet each of their unique situations. Those that do will be well informed to make decisions; those that don’t may be left out of the next industrial revolution. DOWNLOAD